A pharmaceutical composition suitable for lymphatic drug administration in which an anticancer agent is administered into lymph nodes is provided. A pharmaceutical composition for cancer treatment or prophylactic treatment for intralymph node administration, comprising as an active ingredient one or more anticancer agents selected from antimetabolites and plant alkaloid anticancer agents.
展开▼